Literature DB >> 9781985

Tumor reduction in vivo after adenoviral mediated gene transfer of the herpes simplex virus thymidine kinase gene and ganciclovir treatment in human head and neck squamous cell carcinoma.

E A Goebel, B L Davidson, S M Graham, J A Kern.   

Abstract

Gene transfer offers the possibility of novel therapies for head and neck squamous cell carcinoma (HNSCC). To this end, we demonstrate that a replication deficient adenovirus vector (Ad.RSVlacZ) can efficiently transduce foreign genes into human HNSCC cell lines in vitro, and that adenoviral mediated transfer of herpes simplex virus thymidine kinase (Ad.RSVtk) followed by exposure to ganciclovir results in tumor cell killing in vitro and in vivo. Exposure to Ad.RSVlacZ resulted in lacZ expression at multiplicities of infection (MOIs) of 10 and 100 for the cell lines HEp-2 and FaDu, respectively. This increased to 97% (HEp-2) and 49% (FaDu) at an MOI of 10,000. For HEp-2, maximum expression occurred during the first 48 hours after exposure (52% at 24 hours, 48% at 48 hours; MOI 500), then declined by 40% per day. This rapid decline may be caused by dilution of the gene through cell proliferation, because normalizing for the increase in total protein shows that the total number of cells expressing lacZ is stable from days 1 to 4. FaDu and HEp-2 were then transduced by AD.RSVtk and exposed to 20 microM ganciclovir for 24 hours. Significant tumor cell killing, as measured by a colony forming assay, occurred at an MOI of 2 for HEp-2 and 20 for FaDu. At an MOI of 200, 100% of HEp-2 and 97% of FaDu cells were killed. Next, subcutaneous tumor nodules derived from FaDu and HEp-2 were established in the flanks of SCID mice. Direct intratumoral injection of Ad.RSVtk followed by 7 days of ganciclovir therapy resulted in an adenovirus dose dependent reduction of tumor growth, and an actual size reduction of established tumor nodules at the highest does (10(10) plaque forming units). In conclusion, an adenovirus vector can efficiently transduce HNSCC cell lines in vitro. Maximum marker gene expression occurred during the first 48 hours after transduction. Transduction by Ad.RSVtk followed by exposure to ganciclovir resulted in tumor cell killing in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781985     DOI: 10.1016/S0194-5998(98)70073-7

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  4 in total

1.  Silk-elastinlike protein polymers improve the efficacy of adenovirus thymidine kinase enzyme prodrug therapy of head and neck tumors.

Authors:  Khaled Greish; Jordan Frandsen; Stephanie Scharff; Joshua Gustafson; Joseph Cappello; Daqing Li; Bert W O'Malley; Hamidreza Ghandehari
Journal:  J Gene Med       Date:  2010-07       Impact factor: 4.565

Review 2.  Local delivery for gene therapy.

Authors:  G L Clayman; L Dreiling
Journal:  Curr Oncol Rep       Date:  1999       Impact factor: 5.075

3.  Silk-elastinlike protein polymer hydrogels for localized adenoviral gene therapy of head and neck tumors.

Authors:  Khaled Greish; Koji Araki; Daqing Li; Bert W O'Malley; Ramesh Dandu; Jordan Frandsen; Joseph Cappello; Hamidreza Ghandehari
Journal:  Biomacromolecules       Date:  2009-08-10       Impact factor: 6.988

4.  Serum decreases the size of Metafectene-and Genejammer-DNA complexes but does not affect significantly their transfection activity in SCCVII murine squamous cell carcinoma cells.

Authors:  Krystyna Konopka; Nathan Overlid; Anitha C Nagaraj; Nejat Düzgüneş
Journal:  Cell Mol Biol Lett       Date:  2006       Impact factor: 5.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.